BioCentury
ARTICLE | Company News

DevCo, BASF deal

May 10, 1999 7:00 AM UTC

DevCo and BASF's pharmaceutical arm, Knoll AG (Ludwigshafen, Germany) agreed to jointly develop a drug candidate to treat Parkinson's disease. DevCo will design and run Phase II clinical trials, plann...